Inhibition of endothelial SCUBE2, a novel VEGFR2 co-receptor, suppresses tumor angiogenesis

被引:0
|
作者
Lin, Yuh-Charn
Liu, Chun-Yu
Kannagi, Reiji
Yang, Ruey-Bing
机构
来源
FASEB JOURNAL | 2018年 / 32卷 / 01期
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
804.23
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Gremlin is a novel agonist of the major proangiogenic receptor VEGFR2
    Mitola, Stefania
    Ravelli, Cosetta
    Moroni, Emanuela
    Salvi, Valentina
    Leali, Daria
    Ballmer-Hofer, Kurt
    Zammataro, Luca
    Presta, Marco
    BLOOD, 2010, 116 (18) : 3677 - 3680
  • [32] Computational Modeling to Quantify the Contributions of VEGFR1, VEGFR2, and Lateral Inhibition in Sprouting Angiogenesis
    Kuehn, Clemens
    Checa, Sara
    FRONTIERS IN PHYSIOLOGY, 2019, 10
  • [33] Artemisinin derivative FO-ARS-123 as a novel VEGFR2 inhibitor suppresses angiogenesis, cell migration, and invasion
    Lu, Xiaohua
    Elbadawi, Mohamed
    Blatt, Sebastian
    Saeed, Mohamed E. M.
    Xiao, Xiaolin
    Ma, Xiao
    Fleischer, Edmond
    Kammerer, Peer W.
    Efferth, Thomas
    CHEMICO-BIOLOGICAL INTERACTIONS, 2022, 365
  • [34] TIE2-high cervical cancer cells promote tumor angiogenesis by upregulating TIE2 and VEGFR2 in endothelial cells
    Tan, Shuran
    Chen, Yuanyuan
    Du, Shi
    Li, Wenhan
    Liu, Pan
    Zhao, Jing
    Yang, Ping
    Cai, Jing
    Gao, Rui
    Wang, Zehua
    TRANSLATIONAL ONCOLOGY, 2022, 26
  • [35] Silencing of Plvap expression inhibits angiogenesis by reducing VEGFR2 levels in endothelial cells
    Wisniewska-Kruk, Joanna
    Klaassen, Ingeborg
    Vogels, Ilse M. C.
    Van Noorden, Cornelis J. F.
    Giffioen, Arjan W.
    Schlingemann, Reinier O.
    ANGIOGENESIS, 2014, 17 (03) : 757 - 757
  • [36] Endothelial ELABELA improves post-ischemic angiogenesis by upregulating VEGFR2 expression
    Peng, Jia-Yu
    Fu, Xiao
    Luo, Xue-Yang
    Liu, Fang
    Zhang, Bing
    Zhou, Bin
    Sun, Kun
    Chen, Alex F.
    TRANSLATIONAL RESEARCH, 2024, 270 : 13 - 23
  • [37] Deltonin inhibits angiogenesis by regulating VEGFR2 and subsequent signaling pathways in endothelial cells
    Tong, Qingyi
    Zhao, Qingbing
    Qing, Yong
    Hu, Xiaojuan
    Jiang, Lei
    Wu, Xiaohua
    STEROIDS, 2015, 96 : 30 - 36
  • [38] Aiphanol, a native compound, suppresses angiogenesis via dual-targeting VEGFR2 and COX2
    Chen, Shanmei
    Feng, Junnan
    Zhao, Chuanke
    Wang, Lixin
    Meng, Lin
    Liu, Caiyun
    Cai, Shaoqing
    Jia, Yanxing
    Qu, Like
    Shou, Chengchao
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [39] Sinensetin suppresses angiogenesis in liver cancer by targeting the VEGF/VEGFR2/AKT signaling pathway
    Li, Xiao
    Li, Yan
    Wang, Yuan
    Liu, Fuhong
    Liu, Yanjun
    Liang, Jiangjiu
    Zhan, Rucai
    Wu, Yue
    Ren, He
    Zhang, Xiuyuan
    Liu, Ju
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2022, 23 (05)
  • [40] PPemd26, an anthraquinone derivative, suppresses angiogenesis via inhibiting VEGFR2 signalling
    Huang, S. W.
    Lien, J. C.
    Kuo, S. C.
    Huang, T. F.
    BRITISH JOURNAL OF PHARMACOLOGY, 2014, 171 (24) : 5728 - 5742